Researchers

HIRASE Chikara

HIRASE Chikara
Associate Professor
Faculty Kindai University Hospital
Researchmap https://researchmap.jp/hirase_chikara

Education and Career

Education

  • 1997/04 - 2003/03 , Kindai University, Faculty of Medicine,
  • 2005/04 - 2009/03 , Kindai University, Graduate School of Medical Sciences,

Academic & Professional Experience

  • May. 2025 - Today , Kindai University Faculty of Medicine Associate Professor
  • Sep. 2023 - May. 2025 , Kindai University Faculty of Medicine lecturer
  • Apr. 2018 - Today , Kindai University 臨床研究センター 講師
  • Apr. 2016 - Mar. 2018 , Pharmaceuticals and Medical Devices Agency new drug V reviewer
  • Apr. 2013 - Mar. 2018 , Kindai University Faculty of Medicine 医学部講師
  • Apr. 2009 - Mar. 2013 , Kindai University Faculty of Medicine 助教

Research Activities

Research Areas

  • Life sciences , Hematology and oncology

Research Interests

clinical research, Regulatory science, drug lag, hematopoietic and lymphoid tumors, chronic myeloid leukemia, Ph-positive acute lymphoblastic leukemia

Published Papers

  1. CD34+ and CD34− MM cells show different immune-checkpoint molecule expression profiles: high expression of CD112 and CD137 ligand on CD34+ MM cells
    Ayano Fukui-Morimoto; Kentaro Serizawa; Ko Fujimoto; Aki Hanamoto; Yoshio Iwata; Hiroaki Kakutani; Takahiro Kumode; Chikara Hirase; Yasuyoshi Morita; Yoichi Tatsumi; Hitoshi Hanamoto; Hirokazu Tanaka; Itaru Matsumura
    International Journal of Hematology  121  (1)  , 89-99, 12, Nov. 2024 
  2. Long-Term Clinical Outcomes of the Patients with Chronic Myeloid Leukemia Treated with Nilotinib as the 1st-Line Tyrosine Kinases Inhibitor at the Kindai university hospital
    Hirase Chikara; Matsumura Itaru; Kumode Takahiro; Serizawa Kentaro; Morita Yasuyoshi; Tanaka Hirokazu; Fukuoka Kazuya
    ACTA MEDICA KINKI UNIVERSITY  49  (1)  , 15-25, 20, Jun. 2024  , Refereed
  3. Comparative Analysis of the Hemodynamic Effects of Remimazolam and Propofol During General Anesthesia: A Retrospective Study
    Shota Tsukimoto; Atsuhiro Kitaura; Rina Yamamoto; Chikara Hirase; Shinichi Nakao; Yasufumi Nakajima; Takuro Sanuki
    Cureus  15, Apr. 2024 

MORE

Books etc

  1. Nihonrinsyo , 平瀬主税 , Chronic myeloid leukemia (CML) , 日本臨牀社 , 2024
  2. ゲノム医療時代のがん : 分子標的薬と診断薬研究 , 西尾和人; 平瀬 主税 ほか , 第2章 ゲノム医療時代のコンパニオン診断薬開発の在り方「これまでのコンパニオン診断薬（CDx）の考え方」 , 羊土社 , Sep. 2020
  3. WHO血液腫瘍分類 : WHO分類2017をうまく活用するために , 直江知樹; 小松則夫; 宮﨑泰司; 中村栄男; 飯田真介; 大島孝一; 木下朝博; 吉野正; 松村到; 平瀬主税; ほか , 骨髄系腫瘍 2章 慢性骨髄性白血病, BCR-ABL1陽性（平瀬主税, 松村到） , 医薬ジャーナル社 , 30, Oct. 2018

MORE

Conference Activities & Talks

  1. Clinical usefulness of Letermovir for patients with stem cell transplantation , 谷口康博; 平瀬主税; 芦田隆司; 波江野高大; 角谷宏明; 源周治; 綿谷陽作; 口分田貴裕; 芹澤憲太郎; 頼晋也; 森田泰慶; 田中宏和; 辰巳陽一; 松村到 , 第43回日本造血細胞移植学会総会 , 5, Mar. 2021
  2. Outcomes of allo-SCT for patients in non-remission especially with chemoresistance , 谷口康博; 芦田隆司; 森田泰慶; 平瀬主税; 頼晋也; 中山聖子; 芹澤憲太郎; 口分田貴裕; 井上宏昭; 岩田吉男; 谷口貴英; 源周治; 角谷宏明; 藤本昂; 小森舞子; 波江野高大; 三宅義昭; 辰巳陽一; 田中宏和; 松村到 , 第42回日本造血細胞移植学会総会 , 5, Mar. 2020
  3. 早期臨床試験（FIH試験を含む）について , 令和元年度大阪府医師会治験セミナー , 4, Nov. 2019

MORE

MISC

  1. Retrospective analysis of autologous stem cell transplantation for Diffuse large B-cell lymphoma , 波江野高大; 三宅義昭; 井上舞子; 藤本昂; 角谷宏明; 藤井晶; 源周治; 口分田貴裕; 芹澤憲太郎; 谷口康博; 頼晋也; 平瀬主悦; 森田泰慶; 田中宏和; 辰巳陽一; 芦田隆司; 松村到 , 日本造血・免疫細胞療法学会総会プログラム・抄録集 , 44th , 2022
  2. Clinical usefulness of Letermovir for patients with stem cell transplantation , 谷口康博; 平瀬主税; 芦田隆司; 波江野高大; 角谷宏明; 源周治; 綿谷陽作; 口分田貴裕; 芹澤憲太郎; 頼晋也; 森田泰慶; 田中宏和; 辰巳陽一; 松村到 , 日本造血細胞移植学会総会プログラム・抄録集 , 43rd , 2021
  3. Recent topics in the development of anticancer drugs , 平瀬主税; 佐野圭吾; 福岡和也 , 近畿大学医学雑誌 , 46 , 1-2 , 2021

MORE

Awards & Honors

  1. 2011, 公益財団法人大阪対がん協会, がん研究助成奨励金

Research Grants & Projects

  1. Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Development of novel anti-leukemic therapy targeting clathrin-dependent endocytosis , Kindai University
  2. Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Identification and characterization of CML stem cell during TKI treatment , Kinki University
  3. Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Novel therapeutic approaches targeting intracellular trafficking of RTK mutants in acute myeloid leukemia cells. , Kinki University